Epofit 6000 IU Injection: Comprehensive Medicine Guide
When to Call Your Doctor IMMEDIATELY
- Chest pain, shortness of breath, or difficulty breathing
- Sudden weakness or numbness on one side of the body
- Severe headache with confusion or visual changes
- Swelling, pain, or redness in one leg
- Sudden loss of response to therapy or severe fatigue
- Seizures
- Signs of allergic reaction: rash, itching, swelling of face/lips/throat
If experiencing severe symptoms, call emergency services immediately.
What is zyrop 6000iu injection used for?
This medicine is a recombinant human erythropoietin alfa injection used to treat anemia in chronic kidney disease, chemotherapy-induced anemia, and anemia in HIV patients on zidovudine. It stimulates red blood cell production and must be administered by a healthcare professional.
- Generic Name: Recombinant Human Erythropoietin Alfa (6000IU)
- Manufacturer: Zydus Cadila
- Form: Allopathy
- Pregnancy Category: Consult doctor
- Prescription Required: Yes
🇮🇳 zyrop 6000iu injection के बारे में (Hindi Summary)
उपयोग: यह दवा रक्ताल्पता (एनीमिया) के इलाज के लिए उपयोग की जाती है, विशेष रूप से क्रोनिक किडनी रोग, कीमोथेरेपी से होने वाली एनीमिया, और एचआईवी रोगियों में जिडोवुडीन के कारण होने वाली एनीमिया में। यह लाल रक्त कोशिकाओं के उत्पादन को उत्तेजित करती है। यह इंजेक्शन के रूप में दी जाती है और इसे डॉक्टर या नर्स द्वारा ही लगाया जाना चाहिए।
साइड इफेक्ट्स: सामान्य दुष्प्रभावों में उच्च रक्तचाप, सिरदर्द, थकान, दस्त, मतली, उल्टी और इंजेक्शन स्थल पर प्रतिक्रिया शामिल हैं। गंभीर दुष्प्रभावों में दिल का दौरा, स्ट्रोक, रक्त के थक्के, दौरे और शुद्ध लाल कोशिका अप्लासिया शामिल हो सकते हैं। यदि आपको सीने में दर्द, सांस लेने में कठिनाई, या पैरों में सूजन हो, तो तुरंत डॉक्टर से संपर्क करें।
सुरक्षा सलाह: यह दवा केवल डॉक्टर की देखरेख में ही दी जानी चाहिए। स्वयं इंजेक्शन न लगाएं। नियमित रूप से हीमोग्लोबिन, रक्तचाप और आयरन की जांच कराएं। गर्भावस्था या स्तनपान के दौरान डॉक्टर से सलाह लें। इस दवा को 2-8°C पर रेफ्रिजरेटर में रखें, जमने न दें।
💊 zyrop 6000iu injection Uses & Benefits
[{"condition":"Anemia of chronic kidney disease","description":"This medicine is used to treat anemia in patients with chronic kidney disease, including those on dialysis and not on dialysis, to reduce the need for blood transfusions.","evidence":"Well-established"},{"condition":"Chemotherapy-induced anemia","description":"It is used to treat anemia in cancer patients receiving myelosuppressive chemotherapy, with the goal of reducing transfusion requirements.","evidence":"Well-established"},{"condition":"Anemia in HIV-infected patients on zidovudine","description":"This medicine is indicated for anemia associated with zidovudine therapy in HIV-infected patients.","evidence":"Well-established"},{"condition":"Anemia in patients undergoing surgery","description":"It may be used to reduce the need for allogeneic blood transfusions in patients undergoing elective surgery with anticipated significant blood loss.","evidence":"Established"}]
Off-label uses: [{"condition":"Anemia in myelodysplastic syndromes","description":"Sometimes used off-label to treat anemia in patients with low-risk myelodysplastic syndromes.","evidence":"Limited"},{"condition":"Anemia of prematurity","description":"Off-label use in premature infants to reduce transfusion needs.","evidence":"Limited"}]
Primary treatment for: Anemia associated with chronic kidney disease
Also treats: Chemotherapy-induced anemia, Anemia in HIV-infected patients on zidovudine, Anemia in patients undergoing surgery
📋 Drug Information
| Generic Name(s) | Recombinant Human Erythropoietin Alfa (6000IU) |
| Brand Name | zyrop 6000iu injection |
| Manufacturer | Zydus Cadila |
| Packaging / Form | Varies by brand (Allopathy) |
| Therapeutic Class | BLOOD RELATED |
| Action Class | Erythropoiesis-stimulating agent (ESA) |
| Route of Administration | Parenteral (intravenous or subcutaneous) |
| Storage | Store refrigerated at 2°C to 8°C. Do not freeze. Do not shake. Protect from light. Keep in original carton until use. |
| Shelf Life | Refer to the product packaging for the expiration date. Typically 24 months from the date of manufacture when stored properly. |
| WHO Guideline | WHO guidelines recommend the use of erythropoiesis-stimulating agents for the treatment of anemia in chronic kidney disease and cancer patients, with careful monitoring of hemoglobin levels to avoid excessive increases. |
| ICMR Guideline | ICMR guidelines recommend individualized dosing of erythropoietin in chronic kidney disease patients, with target hemoglobin levels between 10-12 g/dL, and regular monitoring of iron status and blood pressure. |
👨⚕️ Doctor's Practical Tips
Evidence-based practical advice from experienced clinicians
🔍 Is This Medicine Right for Your Symptom?
Educational reference. Always consult a doctor for diagnosis.
🔬 How This Medicine Works (Pharmacology)
Pharmacokinetics
How It Works
Recombinant human erythropoietin alfa binds to erythropoietin receptors on the surface of erythroid progenitor cells in the bone marrow. This binding activates intracellular signaling pathways, primarily the JAK2/STAT5 pathway, which promotes cell survival, proliferation, and differentiation into mature red blood cells. It also stimulates the release of reticulocytes into the bloodstream, thereby increasing red blood cell production and hemoglobin levels.
Mechanism Steps
💡 How to Take zyrop 6000iu injection
Strength: Injection: 6000 IU per vial or prefilled syringe.
Dosage Information
| Adult Dosage | The dose of this medicine must be individualized by a qualified clinician based on the indication, patient's age, weight, renal and hepatic function, and response to therapy. For chronic kidney disease, typical starting dose is 50-100 IU/kg three times weekly, adjusted to maintain hemoglobin between 10-12 g/dL. For chemotherapy-induced anemia, typical dose is 150 IU/kg three times weekly or 40,000 IU weekly. For zidovudine-treated HIV patients, typical dose is 100 IU/kg three times weekly. Always follow your doctor's prescription. |
| Pediatric Dosage | Pediatric dosing is not established from available information. Consult a pediatrician. |
| Elderly Dosage | Elderly patients may be more sensitive to the effects of this medicine. Dose selection should be cautious, reflecting the greater frequency of decreased renal, hepatic, or cardiac function. Monitor closely. |
| Renal Impairment | In patients with chronic kidney disease, dose adjustment is required based on hemoglobin levels and clinical response. Monitor renal function and hemoglobin regularly. Dose must be individualized by a qualified clinician. |
| Hepatic Impairment | No specific dose adjustments are established for hepatic impairment. Use with caution and monitor closely. |
| Maximum Daily Dose | Not established from the available information. Dosing is individualized and not typically administered daily. |
Dosage Timeline
⏰ What to Do If You Miss a Dose
⚠️ Side Effects of zyrop 6000iu injection
✅ Common Side Effects
🚨 Serious Side Effects
⚠️ Rare Side Effects
Consult your doctor if you experience any unusual symptoms.
🔬 Drug Interactions
| Drug | Severity | Effect |
|---|---|---|
| Other ESAs | Major | |
| ACE inhibitors | Moderate | |
| ARBs | Moderate | |
| Iron supplements | Minor |
🚨 Major Interactions
- Other erythropoiesis-stimulating agents
⚡ Moderate Interactions
- Angiotensin-converting enzyme inhibitors
- Angiotensin II receptor blockers
🍷 Alcohol Interaction
Alcohol may worsen anemia and increase the risk of hypertension. It is advisable to avoid or limit alcohol consumption while receiving this medicine.
🔎 Check Your Other Medicines
Educational tool. Always confirm with your doctor or pharmacist.
🛡️ Safety & Warnings
🚫 Contraindications
["Uncontrolled hypertension","Known hypersensitivity to recombinant human erythropoietin alfa or any excipient","Pure red cell aplasia","Use in patients with chronic kidney disease not on dialysis with hemoglobin >10 g/dL","Use in cancer patients with hemoglobin >12 g/dL"]
⚠️ Warnings & Precautions
["Increased risk of cardiovascular events and thromboembolism when hemoglobin is raised too rapidly or exceeds target levels.","Hypertension may worsen; monitor blood pressure closely.","Seizures have been reported, especially in patients with chronic kidney disease.","Pure red cell aplasia may occur; evaluate if sudden loss of efficacy.","Iron deficiency reduces efficacy; ensure adequate iron stores.","Do not use in patients with uncontrolled hypertension.","Use with caution in patients with history of seizures or cardiovascular disease."]
🤱 Lactation Safety
It is not known whether this medicine is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when administered to a nursing woman. Consult your doctor.
💊 Overdose Management
Overdose may lead to excessive erythropoiesis, resulting in polycythemia and increased risk of thromboembolic events. Treatment is symptomatic and supportive. If overdose is suspected, discontinue the medicine and monitor hemoglobin, hematocrit, and cardiovascular status. Phlebotomy may be considered if severe polycythemia occurs. Seek immediate medical attention.
⏰ Missed Dose
If a dose is missed, contact your healthcare provider for guidance. Do not double the dose to catch up. The dosing schedule is typically individualized; your doctor will advise on the next dose.
Additional Safety Advice
This medicine must only be administered by a healthcare professional. Do not self-administer. Regular monitoring of hemoglobin, blood pressure, and iron levels is essential. Target hemoglobin levels should be individualized, generally not exceeding 11-12 g/dL. Iron supplementation is often required to ensure adequate response. Report any signs of blood clots, such as chest pain, shortness of breath, or swelling in legs, immediately. Avoid use in patients with uncontrolled hypertension. Do not use if you have known hypersensitivity to the active ingredient. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding. Store this medicine refrigerated at 2-8°C; do not freeze. Keep out of reach of children.
👴 Special Considerations for Elderly
💡 For Patients Above 65
Elderly patients may be more sensitive to the effects of this medicine. Dose selection should be cautious, and blood pressure and hemoglobin should be monitored closely.
🤰 Pregnancy Planning (TTC)
If you are planning pregnancy, consult your doctor. This medicine is not recommended during pregnancy unless clearly needed. Discuss risks and benefits.
🏥 Post-Surgery Considerations
This medicine may be used to reduce the need for blood transfusions after surgery. Monitor hemoglobin and blood pressure closely. Follow your surgeon's instructions.
🦷 Dental Procedures
Inform your dentist that you are receiving this medicine. No specific precautions are established, but maintain good oral hygiene and report any bleeding issues.
💚 Lifestyle Tips for Better Results
🏋️ Exercise Considerations
Patients with anemia may experience fatigue and shortness of breath. Engage in light to moderate exercise as tolerated. Avoid strenuous activity until hemoglobin levels improve. Consult your doctor before starting any exercise program.
🥗 Diet Recommendations
💼 Impact on Daily Work & Life
This medicine may cause dizziness or seizures in some patients. Avoid driving or operating heavy machinery until you know how it affects you. Most patients can continue their daily activities, but fatigue may limit strenuous work until anemia improves.
🛑 When to Stop This Medicine
Do not stop this medicine without consulting your doctor. Stopping abruptly may lead to worsening anemia. Your doctor will determine when to stop based on your hemoglobin levels and clinical response.
📅 Long-Term Use Effects
Long-term use of this medicine may increase the risk of cardiovascular events, thromboembolism, and hypertension. Regular monitoring of hemoglobin, blood pressure, and iron levels is essential. Pure red cell aplasia is a rare but serious complication that may occur after long-term use. The dose should be adjusted to maintain target hemoglobin levels and minimize risks.
🌿 Non-Medicine Approaches
These can complement medicine but do not replace prescribed treatment.
May be used alone or in combination with this medicine to treat iron deficiency anemia.
Evidence: Well-establishedUsed for severe anemia or when ESAs are ineffective.
Evidence: Well-established💉 Vaccination Considerations
💉 If You're Getting Vaccinated
No specific interactions with vaccines are established. However, consult your doctor before receiving any vaccine while on this medicine.
📦 Storage Guide
✅ DO
Store refrigerated at 2-8°C
❌ DON'T
Do not freeze
✅ DO
Keep in original carton to protect from light
❌ DON'T
Do not shake
✅ DO
Keep out of reach of children
❌ DON'T
Do not use if expired
✈️ Traveling with This Medicine
When traveling with this medicine, carry it in its original packaging with the prescription label. Keep it refrigerated using a cool pack or insulated bag. Carry a copy of your prescription and a doctor's letter explaining the medical need. Check airline and customs regulations for carrying injectable medications. Do not freeze. If traveling across time zones, consult your doctor for dose timing adjustments.
💰 Cost Analysis & Savings
👥 Real Patient Stories
Educational, anonymized scenarios. Individual results may vary.
💬 Questions Patients Often Ask
A: It typically takes 2-6 weeks to see an increase in hemoglobin levels. Regular monitoring is required.
A: No, this medicine must be administered by a healthcare professional.
A: Contact your healthcare provider for guidance. Do not double the dose.
A: Consult your doctor. It is not recommended unless clearly needed.
🤔 Common Patient Concerns
🔄 Substitutes for zyrop 6000iu injection
View AllAlternative brands with exact same active ingredient:
-
erypro safe 6000iu injectionBiocon ₹1,287.51 23.7% CHEAPER
-
epofer 6000iu injectionEmcure Pharmaceuticals Ltd ₹1,368.28 18.9% CHEAPER
-
vintor 6000iu injectionEmcure Pharmaceuticals Ltd ₹1,591.00 5.7% CHEAPER
-
epotrust 6000iu solution for injectionPanacea Biotec Ltd ₹1,897.32 12.4% COSTLIER
-
anfoe 6000iu injectionLa Renon Healthcare Pvt Ltd ₹1,959.38 16.1% COSTLIER
Medical Note: Always consult your doctor before switching medications.
🛑 Myths vs. Facts
- Myth: This medicine can be used as a performance enhancer by athletes.
Fact: This medicine is a prescription medication for specific medical conditions and should not be used for performance enhancement. It can cause serious cardiovascular risks. - Myth: This medicine can be taken orally.
Fact: This medicine is a protein and would be digested if taken orally. It must be given by injection. - Myth: More is better; higher doses increase energy.
Fact: Higher doses can dangerously increase hemoglobin and risk of blood clots, heart attack, and stroke. Dose is carefully individualized.
🔄 Alternative Options
Generic Alternatives
- Recombinant human erythropoietin alfa
Brand Alternatives
- Epofit 6000 IU Injection
- Eprex 6000 IU Injection
- Recormon 6000 IU Injection